🔴 Solid Biosciences is trading 5.27% down today; company-specific catalyst unconfirmed

Solid Biosciences is trading at $8.45, down 5.27%, with no verified company-specific catalyst identified for September 23, 2026.

• Broader risk-off trading may be contributing, with the Nasdaq down 1.00%.
• No company-specific announcement, earnings release, FDA update, or clinical-trial news was identified; investor-relations releases show no new dated catalyst. Biotech sector strength does not explain the decline.